Translational Initiative to Map Epigenetics in Sleep
NCT06333301
Biological Aging
View Trial DetailsNCT Number: NCT05760547
The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
TIME-A is a longitudinal research initiative. Anyone who has ever taken an Index test registered through Elysium Health is eligible to participate. Participation involves answering questions that will be administered via a survey format. Research participants' survey responses will be combined with their epigenetic Index data with the primary aim of identifying the contributions of 1) environmental and lifestyle factors, 2) general health, and 3) medical history, on biological age. Exploratory aims include the development of epigenetic signatures that are predictive of health status, and exploring the relationship between epigenetically-derived health phenotypes and biological age. These findings will lay the foundation for personalized health recommendations using Index (including, but not limited to: workout routines, diets, supplement regimens, medications, lifestyle changes).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline and throughout study (approximately every 6 months up to 120 months)
Univariate and multivariate statistical methods will be used to identify which environmental and lifestyle factors (from TIME-A survey responses) influence biological age.
Time frame: At baseline and throughout study (approximately every 6 months up to 120 months)
Univariate and multivariate statistical methods will be used to identify which general health characteristics (from TIME-A survey responses) influence biological age.
Time frame: At baseline and throughout study (approximately every 6 months up to 120 months)
Univariate and multivariate statistical methods will be used to identify the impact of medical history (from TIME-A survey responses) on biological age.
Time frame: At baseline and throughout study (approximately every 6 months up to 120 months)
DNA methylation data and TIME-A survey responses will be combined. Supervised and unsupervised machine learning methods will be used to generate novel methylation-derived predictors of participants' survey responses.
Contact information is provided by the study sponsor or research team.
Elysium Health
Industry
Acronym: TIME-A
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06333301
Biological Aging
View Trial DetailsNCT06555978
Biological Aging, Healthy Aging
Singapore
View Trial DetailsNCT07579845
Biological Aging, Detoxification
Richmond, Virginia, United States
View Trial DetailsNCT05880095
Behavior, Biological Aging
Madrid, Spain
View Trial Details